China Cystic Fibrosis Drugs Market Report & Forecast 2021-2027

China Cystic Fibrosis Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cystic Fibrosis Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Cystic Fibrosis Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Cystic Fibrosis Drugs Overall Market Size
2.1 China Cystic Fibrosis Drugs Market Size: 2021 VS 2027
2.2 China Cystic Fibrosis Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China Cystic Fibrosis Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Cystic Fibrosis Drugs Players in China Market
3.2 Top China Cystic Fibrosis Drugs Companies Ranked by Revenue
3.3 China Cystic Fibrosis Drugs Revenue by Companies
3.4 China Cystic Fibrosis Drugs Sales by Companies
3.5 China Cystic Fibrosis Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Cystic Fibrosis Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers Cystic Fibrosis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cystic Fibrosis Drugs Players in China Market
3.8.1 List of Tier 1 Cystic Fibrosis Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 Cystic Fibrosis Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Cystic Fibrosis Drugs Market Size Markets, 2021 & 2027
4.1.2 Oral Cystic Fibrosis Drugs
4.1.3 Injection Cystic Fibrosis Drugs
4.2 By Type - China Cystic Fibrosis Drugs Revenue & Forecasts
4.2.1 By Type - China Cystic Fibrosis Drugs Revenue, 2016-2021
4.2.2 By Type - China Cystic Fibrosis Drugs Revenue, 2022-2027
4.2.3 By Type - China Cystic Fibrosis Drugs Revenue Market Share, 2016-2027
4.3 By Type - China Cystic Fibrosis Drugs Sales & Forecasts
4.3.1 By Type - China Cystic Fibrosis Drugs Sales, 2016-2021
4.3.2 By Type - China Cystic Fibrosis Drugs Sales, 2022-2027
4.3.3 By Type - China Cystic Fibrosis Drugs Sales Market Share, 2016-2027
4.4 By Type - China Cystic Fibrosis Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Cystic Fibrosis Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - China Cystic Fibrosis Drugs Revenue & Forecasts
5.2.1 By Application - China Cystic Fibrosis Drugs Revenue, 2016-2021
5.2.2 By Application - China Cystic Fibrosis Drugs Revenue, 2022-2027
5.2.3 By Application - China Cystic Fibrosis Drugs Revenue Market Share, 2016-2027
5.3 By Application - China Cystic Fibrosis Drugs Sales & Forecasts
5.3.1 By Application - China Cystic Fibrosis Drugs Sales, 2016-2021
5.3.2 By Application - China Cystic Fibrosis Drugs Sales, 2022-2027
5.3.3 By Application - China Cystic Fibrosis Drugs Sales Market Share, 2016-2027
5.4 By Application - China Cystic Fibrosis Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Actavis
6.1.1 Actavis Corporation Information
6.1.2 Actavis Overview
6.1.3 Actavis Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 Actavis Cystic Fibrosis Drugs Product Description
6.1.5 Actavis Recent Developments
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Overview
6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Description
6.2.5 F. Hoffmann-La Roche Recent Developments
6.3 Gilead Sciences
6.3.1 Gilead Sciences Corporation Information
6.3.2 Gilead Sciences Overview
6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 Gilead Sciences Cystic Fibrosis Drugs Product Description
6.3.5 Gilead Sciences Recent Developments
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Overview
6.4.3 Novartis Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 Novartis Cystic Fibrosis Drugs Product Description
6.4.5 Novartis Recent Developments
6.5 Vertex Pharmaceuticals
6.5.1 Vertex Pharmaceuticals Corporation Information
6.5.2 Vertex Pharmaceuticals Overview
6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Description
6.5.5 Vertex Pharmaceuticals Recent Developments
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Overview
6.6.3 Abbott Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.6.4 Abbott Cystic Fibrosis Drugs Product Description
6.6.5 Abbott Recent Developments
6.7 Anthera Pharmaceuticals
6.7.1 Anthera Pharmaceuticals Corporation Information
6.7.2 Anthera Pharmaceuticals Overview
6.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.7.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Description
6.7.5 Anthera Pharmaceuticals Recent Developments
6.8 Arcturus Therapeutics
6.8.1 Arcturus Therapeutics Corporation Information
6.8.2 Arcturus Therapeutics Overview
6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Description
6.8.5 Arcturus Therapeutics Recent Developments
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Overview
6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Description
6.9.5 Boehringer Ingelheim Recent Developments
6.10 Chiesi Farmaceutici
6.10.1 Chiesi Farmaceutici Corporation Information
6.10.2 Chiesi Farmaceutici Overview
6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Description
6.10.5 Chiesi Farmaceutici Recent Developments
6.11 Corbus Pharmaceuticals
6.11.1 Corbus Pharmaceuticals Corporation Information
6.11.2 Corbus Pharmaceuticals Overview
6.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.11.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Description
6.11.5 Corbus Pharmaceuticals Recent Developments
6.12 Genzyme
6.12.1 Genzyme Corporation Information
6.12.2 Genzyme Overview
6.12.3 Genzyme Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.12.4 Genzyme Cystic Fibrosis Drugs Product Description
6.12.5 Genzyme Recent Developments
6.13 Insmed
6.13.1 Insmed Corporation Information
6.13.2 Insmed Overview
6.13.3 Insmed Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.13.4 Insmed Cystic Fibrosis Drugs Product Description
6.13.5 Insmed Recent Developments
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Overview
6.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.14.4 Johnson & Johnson Cystic Fibrosis Drugs Product Description
6.14.5 Johnson & Johnson Recent Developments
6.15 Merck Sharp & Dohme
6.15.1 Merck Sharp & Dohme Corporation Information
6.15.2 Merck Sharp & Dohme Overview
6.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.15.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Description
6.15.5 Merck Sharp & Dohme Recent Developments
6.16 Neovii Biotech
6.16.1 Neovii Biotech Corporation Information
6.16.2 Neovii Biotech Overview
6.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.16.4 Neovii Biotech Cystic Fibrosis Drugs Product Description
6.16.5 Neovii Biotech Recent Developments
6.17 Novo Nordisk
6.17.1 Novo Nordisk Corporation Information
6.17.2 Novo Nordisk Overview
6.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.17.4 Novo Nordisk Cystic Fibrosis Drugs Product Description
6.17.5 Novo Nordisk Recent Developments
6.18 PharmaSwiss
6.18.1 PharmaSwiss Corporation Information
6.18.2 PharmaSwiss Overview
6.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.18.4 PharmaSwiss Cystic Fibrosis Drugs Product Description
6.18.5 PharmaSwiss Recent Developments
6.19 Pharmaxis
6.19.1 Pharmaxis Corporation Information
6.19.2 Pharmaxis Overview
6.19.3 Pharmaxis Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.19.4 Pharmaxis Cystic Fibrosis Drugs Product Description
6.19.5 Pharmaxis Recent Developments
6.20 Proteostasis Therapeutics
6.20.1 Proteostasis Therapeutics Corporation Information
6.20.2 Proteostasis Therapeutics Overview
6.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.20.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Description
6.20.5 Proteostasis Therapeutics Recent Developments
6.21 PTC Therapeutics
6.21.1 PTC Therapeutics Corporation Information
6.21.2 PTC Therapeutics Overview
6.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.21.4 PTC Therapeutics Cystic Fibrosis Drugs Product Description
6.21.5 PTC Therapeutics Recent Developments
6.22 United Medical
6.22.1 United Medical Corporation Information
6.22.2 United Medical Overview
6.22.3 United Medical Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.22.4 United Medical Cystic Fibrosis Drugs Product Description
6.22.5 United Medical Recent Developments
6.23 Venus Remedies
6.23.1 Venus Remedies Corporation Information
6.23.2 Venus Remedies Overview
6.23.3 Venus Remedies Cystic Fibrosis Drugs Sales and Revenue in China Market (2016-2021)
6.23.4 Venus Remedies Cystic Fibrosis Drugs Product Description
6.23.5 Venus Remedies Recent Developments
7 China Cystic Fibrosis Drugs Production Capacity, Analysis
7.1 China Cystic Fibrosis Drugs Production Capacity, 2016-2027
7.2 Cystic Fibrosis Drugs Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Cystic Fibrosis Drugs Supply Chain Analysis
9.1 Cystic Fibrosis Drugs Industry Value Chain
9.2 Cystic Fibrosis Drugs Upstream Market
9.3 Cystic Fibrosis Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Cystic Fibrosis Drugs Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Cystic Fibrosis Drugs in China Market
Table 2. Top Cystic Fibrosis Drugs Players in China Market, Ranking by Revenue (2019)
Table 3. China Cystic Fibrosis Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Cystic Fibrosis Drugs Revenue Share by Companies, 2016-2021
Table 5. China Cystic Fibrosis Drugs Sales by Companies, (K Pcs), 2016-2021
Table 6. China Cystic Fibrosis Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Cystic Fibrosis Drugs Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Cystic Fibrosis Drugs Product Type
Table 9. List of Tier 1 Cystic Fibrosis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cystic Fibrosis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral Cystic Fibrosis Drugs
Table 12. Major Manufacturers of Injection Cystic Fibrosis Drugs
Table 13. By Type - China Cystic Fibrosis Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Cystic Fibrosis Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Cystic Fibrosis Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Cystic Fibrosis Drugs Sales (K Pcs), 2016-2021
Table 17. By Type - China Cystic Fibrosis Drugs Sales (K Pcs), 2022-2027
Table 18. By Application - China Cystic Fibrosis Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Cystic Fibrosis Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Cystic Fibrosis Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Cystic Fibrosis Drugs Sales (K Pcs), 2016-2021
Table 22. By Application - China Cystic Fibrosis Drugs Sales (K Pcs), 2022-2027
Table 23. Actavis Corporation Information
Table 24. Actavis Description and Major Businesses
Table 25. Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Actavis Cystic Fibrosis Drugs Product
Table 27. Actavis Recent Developments
Table 28. F. Hoffmann-La Roche Corporation Information
Table 29. F. Hoffmann-La Roche Description and Major Businesses
Table 30. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product
Table 32. F. Hoffmann-La Roche Recent Developments
Table 33. Gilead Sciences Corporation Information
Table 34. Gilead Sciences Description and Major Businesses
Table 35. Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Gilead Sciences Cystic Fibrosis Drugs Product
Table 37. Gilead Sciences Recent Developments
Table 38. Novartis Corporation Information
Table 39. Novartis Description and Major Businesses
Table 40. Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Novartis Cystic Fibrosis Drugs Product
Table 42. Novartis Recent Developments
Table 43. Vertex Pharmaceuticals Corporation Information
Table 44. Vertex Pharmaceuticals Description and Major Businesses
Table 45. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product
Table 47. Vertex Pharmaceuticals Recent Developments
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Major Businesses
Table 50. Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Abbott Cystic Fibrosis Drugs Product
Table 52. Abbott Recent Developments
Table 53. Anthera Pharmaceuticals Corporation Information
Table 54. Anthera Pharmaceuticals Description and Major Businesses
Table 55. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product
Table 57. Anthera Pharmaceuticals Recent Developments
Table 58. Arcturus Therapeutics Corporation Information
Table 59. Arcturus Therapeutics Description and Major Businesses
Table 60. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Arcturus Therapeutics Cystic Fibrosis Drugs Product
Table 62. Arcturus Therapeutics Recent Developments
Table 63. Boehringer Ingelheim Corporation Information
Table 64. Boehringer Ingelheim Description and Major Businesses
Table 65. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Boehringer Ingelheim Cystic Fibrosis Drugs Product
Table 67. Boehringer Ingelheim Recent Developments
Table 68. Chiesi Farmaceutici Corporation Information
Table 69. Chiesi Farmaceutici Description and Major Businesses
Table 70. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. Chiesi Farmaceutici Cystic Fibrosis Drugs Product
Table 72. Chiesi Farmaceutici Recent Developments
Table 73. Corbus Pharmaceuticals Corporation Information
Table 74. Corbus Pharmaceuticals Description and Major Businesses
Table 75. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 76. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product
Table 77. Corbus Pharmaceuticals Recent Developments
Table 78. Genzyme Corporation Information
Table 79. Genzyme Description and Major Businesses
Table 80. Genzyme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 81. Genzyme Cystic Fibrosis Drugs Product
Table 82. Genzyme Recent Developments
Table 83. Insmed Corporation Information
Table 84. Insmed Description and Major Businesses
Table 85. Insmed Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 86. Insmed Cystic Fibrosis Drugs Product
Table 87. Insmed Recent Developments
Table 88. Johnson & Johnson Corporation Information
Table 89. Johnson & Johnson Description and Major Businesses
Table 90. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 91. Johnson & Johnson Cystic Fibrosis Drugs Product
Table 92. Johnson & Johnson Recent Developments
Table 93. Merck Sharp & Dohme Corporation Information
Table 94. Merck Sharp & Dohme Description and Major Businesses
Table 95. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 96. Merck Sharp & Dohme Cystic Fibrosis Drugs Product
Table 97. Merck Sharp & Dohme Recent Developments
Table 98. Neovii Biotech Corporation Information
Table 99. Neovii Biotech Description and Major Businesses
Table 100. Neovii Biotech Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 101. Neovii Biotech Cystic Fibrosis Drugs Product
Table 102. Neovii Biotech Recent Developments
Table 103. Novo Nordisk Corporation Information
Table 104. Novo Nordisk Description and Major Businesses
Table 105. Novo Nordisk Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 106. Novo Nordisk Cystic Fibrosis Drugs Product
Table 107. Novo Nordisk Recent Developments
Table 108. PharmaSwiss Corporation Information
Table 109. PharmaSwiss Description and Major Businesses
Table 110. PharmaSwiss Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 111. PharmaSwiss Cystic Fibrosis Drugs Product
Table 112. PharmaSwiss Recent Developments
Table 113. Pharmaxis Corporation Information
Table 114. Pharmaxis Description and Major Businesses
Table 115. Pharmaxis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 116. Pharmaxis Cystic Fibrosis Drugs Product
Table 117. Pharmaxis Recent Developments
Table 118. Proteostasis Therapeutics Corporation Information
Table 119. Proteostasis Therapeutics Description and Major Businesses
Table 120. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 121. Proteostasis Therapeutics Cystic Fibrosis Drugs Product
Table 122. Proteostasis Therapeutics Recent Developments
Table 123. PTC Therapeutics Corporation Information
Table 124. PTC Therapeutics Description and Major Businesses
Table 125. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 126. PTC Therapeutics Cystic Fibrosis Drugs Product
Table 127. PTC Therapeutics Recent Developments
Table 128. United Medical Corporation Information
Table 129. United Medical Description and Major Businesses
Table 130. United Medical Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 131. United Medical Cystic Fibrosis Drugs Product
Table 132. United Medical Recent Developments
Table 133. Venus Remedies Corporation Information
Table 134. Venus Remedies Description and Major Businesses
Table 135. Venus Remedies Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 136. Venus Remedies Cystic Fibrosis Drugs Product
Table 137. Venus Remedies Recent Developments
Table 138. Cystic Fibrosis Drugs Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs)
Table 139. China Cystic Fibrosis Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 140. Cystic Fibrosis Drugs Market Opportunities & Trends in China Market
Table 141. Cystic Fibrosis Drugs Market Drivers in China Market
Table 142. Cystic Fibrosis Drugs Market Restraints in China Market
Table 143. Cystic Fibrosis Drugs Raw Materials
Table 144. Cystic Fibrosis Drugs Raw Materials Suppliers in China Market
Table 145. Typical Cystic Fibrosis Drugs Downstream
Table 146. Cystic Fibrosis Drugs Downstream Clients in China Market
Table 147. Cystic Fibrosis Drugs Distributors and Sales Agents in China Market
List of Figures
Figure 1. Cystic Fibrosis Drugs Product Picture
Figure 2. Cystic Fibrosis Drugs Segment by Type
Figure 3. Cystic Fibrosis Drugs Segment by Application
Figure 4. China Cystic Fibrosis Drugs Market Overview: 2020
Figure 5. China Cystic Fibrosis Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Cystic Fibrosis Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Cystic Fibrosis Drugs Sales in China Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Cystic Fibrosis Drugs Revenue in 2020
Figure 9. Oral Cystic Fibrosis Drugs Product Picture
Figure 10. Injection Cystic Fibrosis Drugs Product Picture
Figure 11. By Type - China Cystic Fibrosis Drugs Sales Market Share, 2016-2027
Figure 12. By Type - China Cystic Fibrosis Drugs Revenue Market Share, 2016-2027
Figure 13. By Type - China Cystic Fibrosis Drugs Price (USD/Pcs), 2016-2027
Figure 14. Hospitals
Figure 15. Clinics
Figure 16. Other
Figure 17. By Application - China Cystic Fibrosis Drugs Sales Market Share, 2016-2027
Figure 18. By Application - China Cystic Fibrosis Drugs Revenue Market Share, 2016-2027
Figure 19. By Application - China Cystic Fibrosis Drugs Price (USD/Pcs), 2016-2027
Figure 20. Actavis Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. F. Hoffmann-La Roche Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Gilead Sciences Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Novartis Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Vertex Pharmaceuticals Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Abbott Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Anthera Pharmaceuticals Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Arcturus Therapeutics Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Boehringer Ingelheim Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Chiesi Farmaceutici Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Corbus Pharmaceuticals Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Genzyme Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Insmed Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Johnson & Johnson Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Merck Sharp & Dohme Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Neovii Biotech Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Novo Nordisk Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. PharmaSwiss Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pharmaxis Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Proteostasis Therapeutics Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. PTC Therapeutics Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. United Medical Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Venus Remedies Cystic Fibrosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. China Cystic Fibrosis Drugs Production Capacity (K Pcs), 2016-2027
Figure 44. Cystic Fibrosis Drugs Industry Value Chain
Figure 45. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs